glp 1 gip agonist Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research The Effects of Dual GLP-1/GIP
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Qiao Q., Ouwens M.J., Grandy S., Johnsson K., Kostev K
However, clinical research increasingly recognized that patients with metabolic diseases frequently experience clusters of systemic complications, including heart failure (HF), chronic kidney disease (CKD), and fatty liver disease, that single-target drugs historically failed to address comprehensively
BN can also be used for patients with poor blood glucose control alone
The oral switch data is also important
Maimoona Akhtar, orcid.org/0009-0002-1595-2023
